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A rapid , in vivo measurem ent of the penetratio n o f anti viral 
compo unds in to the skin would impro ve o ur ability to 
predict the th erapeuti c effi cacy o f topi ca l t rea tm ents fo r 
herpes simplex viru s (HSV) infectio n . W e have studied the 
concentrati o n of io d odeoxyuridine (IOU) in the stratum 
corn eum of g uinea pig skin by tape strippin g at diffe rent 
tim e po ints after sing le and multiple to pi ca l doses o f the 
dru g . T hese results were correlated w ith the effi cacy of 
to pica l IOU aga inst an ex perim ental cutaneous HSV 
infection . 
T en adhes ive tape strippin gs w ere perfo rm ed 0 11 depi-
la ted guinea pig d o rsum in vivo at seri al interva ls after a 
sing le to pical dose o f e H]IDU. lo do deoxyuridine levels in 
the stratum corneum peak ed at 1-3 h (67-70 m g/ g o f tissue) 
and then g raduall y declined o ver th e next 3-24 h. We h y-
po thesized that the peak IOU stratum corneum concen-
tration would correlate w ith th erapeuti c effi cacy. A cco rd-
ingly, we dete rmin ed the qu antity of IOU in g uinea pig 
stra tum corneum 2 h after a to pical applica ti on o f seven 
different con centrations o f IOU in dim ethylsulfoxide 
(OMSO) and exa min ed the in vivo efficacy of these fo r-
mulations in an experimental d o rsa l cutaneous HSV -1 in-
fection in g uinea pi gs. The results showed an excellent 
co rrel ation between the quan tity of IOU in th e stratum 
corneum and redu ctio n in les io n severity (I' = 0.95-0.97). 
I t is well documented that stratum co rneulll is the rate-lim-iting barrier to drug penetra tion th rough skin [1 -4]. In ad-dition, percutaneous absorption of a drug molecule is influ-enced by conditions of drug appli ca tion such as the anatomic site chosen [1 ,5], the dose administered [6-8], the animal 
species [9-11] , the ve hicle used [9, 12], vi ability of the skin [13 ,14] 
and the duration of applica ti on [9, 13]. These multiple fac tors 
crea te great di ffic ulti es in designing experiments that will predict 
the percutaneous abso rption of a drug molecule. Prio r studi es in 
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Fifteen percent IOU in OM SO pro vided the hig hes t ther-
apeuti c effi cacy (90- 94%). W e also studied the relationship 
between the clini ca l effi cacy o f diffe rent dosin g frequencies 
and the am o unt of IOU in the s tratum corneum. Se rial 
IOU stratum corneum concentratio ns were m easured o ve r 
24 h fo llowin g 1, 2, 3, o r 4 appli ca tio ns per day o f 1, 3, 
and 15 % IOU in OM SO trea tments and parall el effi cacy 
studies o f the diffe rent regimens w cre conducted in the 
animal m odel. Within each dosing frequency, the cumu-
lative amount of dru g in the stratum corn eum correlated 
with the streng th of the tes t fo rmulation and w ith effi cacy 
in the anim al m o del. Fo r each o f the three formul ations 
in creasing the number o f dail y doses fro m o ne up to thre~ 
led to progressive in creases in cumulati ve stratum corn eum 
IOU levels and clinical effi cacy. An in crease in the number 
o f dail y appli ca tions to fo ur had littl e effect on drug effi cacy 
and w as associated with' a plateau in stratum corneum IOU 
levels. 
Stratum co rneum IO U concentratio ns were rapid and 
easy to determine and co rrel ated w ell w ith clini ca l events . 
T his novel m casurem ent could be used to evaluate the skin 
penetratio n of to pica l antivirals to g uide fo rmul atio n and 
dosin g o f trea tments fo r HSV infectio ns. The procedure 
has th e added advantage o f po tenti al use in human subj ects 
in vivo. J fllII es f D el'mafo! 89:598- 602, 1987 
our laboratory have used excised guinea pig skin in Franz diffusion 
cells to demonstrate the importance of skin penetrati on fo r the 
efficacy of topica l anti viral chemotherapy [1 5]. 
The current stud y was designed to in ves ti ga te the feasibility of 
a new measurement of anti viral skin penetration that could be 
performed in vivo . The concept of the present wo rk is deri ved 
fro m the resea rch of Rougier and coworkers [1 6] who observed 
that the percutaneous abso rption of drugs th ro ugh the skin was 
proportional to the amollnt of dru g recovered in the stratum 
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Abbreviations: 
DMSO: dim eth ylsul fox ide 
H SV: herpes simplex vi rus 
IDU: iododcoxyuridinc 
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Corneulll fo ll ow in g a 3D-min top ical appli ca tio n, Thi s Stratu111 
Co rneum dru g rese rvo ir fun cti o n has been no ted by others 11 7- 19 1 
and we co nsid ered that it mi ght be a useful m ea ns to eva lu ate 
top ica l ;lIlti v irals , Herpes simplex v iru s (H SV) first infects and 
repli ca tes in the bJ sal epidermal cell b ye r. The therapeuti c efficacy 
of an y top ica l allti v ira l drugs will depcnd upo n how soon drug 
reaches to this Ins;,1 ccl ilaye r and attains a concentration suffi cient 
to inhibit viru s repli ca tion, The co ncentration o f anti v ira l at the 
basa l epiderm al cell la ye r mi ght be quantitated indirectl y by m ea-
s urin g th e am o unt o f dru g in th e st ratum co rneu III , 
MATERIALS AND METHOD S 
Experimental Animals and Virus Hartle y st rain, o utbred, 
female albino guinea pi gs, 350- 400 g each, were ob tained fro m 
C harles Ri ve r l3reedin g Labo ratori es, In c., Wi lmington, Mas-
sachu setts, Durin g trea tm cnt, animals wcrc ho used in in div idual 
cages, The viru s used in th ese studies was the labo rato ry s train 
HSV- I El lS, orig in a ll y o btained from Andre N ahmias, E m o ry 
Univcrsity, Atlanta , Gcorg ia, Virus stock fo r inoculation of guinea 
pigs was prcpared in Vero cell s (Flow Labo ratories, In c' , Rock-
v ille , Mar yland) :l nd contained 5- 10 X 107 PFU / ml. The con-
centrat io n of IDU that in hi bited H S V- I El lS plaque formation 
by 50% in Vero ce lls W:1S 0, 14 ILg f l11 I 11 8 1, 
Drug Formulations IDU and DMSO w ere o bt:,ined fro m 
Resea rch In du strics Co" Sa lt Lake City, Uta h, I'\I-I]IDU was 
su pplied by M o ra vck Biochcm ica ls In c. , B rca, Ca lifo rnia, T he 
s p ecifi C activity was 10 C i/ mmol and th e conccntrat ion W;lS I 
mCi/ mL T he purity of 13H\lDU was es tab lished by thin-b yer 
c hronutog raph y (TLC) o n a Auorcscellt silica gel plate w ith an 
uppcr phase of eth yl accta te- fo rmi c acid- wate r (60 : 5: 35) liqui d 
phase, A sin g le pcak observed contain ed 96-97% o f the activity , 
Radiolabe led formubtions of lD U were prepared by stirrin g 5 ILl 
of [3HIIDU w ith 2 1111 of each o f the liquid test formulati ons, 
The subsequcnt activit y of the fo rillulati o ns was 50- 100 cpml ILg 
IOU, 
Io dodeox yuridine tcs t formu lat io ns were prepared by disso lv-
ing appropriate concentr:ttions ofIDU in v:1 ried am ounts o fDM SO 
and water. Concentrations of dru g and so lvents arc ex presscd as 
the percent by wcig ht of th c total fo rmu lation, Fo r brcvity, t he 
percent o f formu latio ns that was wate r is sometim es not show n, 
Anin1al Inoculation and Treatment Regimens G uinea pi gs 
We re anesthet ized with intrapcritonca l sodium pentobarbital. Hair 
on t he dorsum was ca rcfull y rem oved w ith an electric clipper and 
a c hemi ca l depi lator y (Nair, Ca rter-Wallace , In c., Ncw York , 
New Yo rk ), A g rid of 4 areas was demarcatcd w ith a pen at thc 
mid back and rump on either sidc of thc spine. In some cx pcri-
ments, o nl y the 2 areas o n thc upper half of the g uinea pi g back 
(Fig 1) we re inocul ated, In ocula tio ns wc rc performed w ith H SV-
1 El l S b y multip le shallow puncturcs w ith a vacci l~at io n instru-
ment 120,2 11 , 111 experim cnts [Q stud y th e dTcct of diffcrcnt fre-
q u e ncies of top ical drug appli ca ti o ns , all four quadrants on thc 
g uinea pig dorsum wc re in oclilated w ith v iru s, The da y of in-
oculation was des ig nated as day 0 , Drug t rea tm ents were bcgun 
24 h POSt in oculation and g iven four times a day for a tota l of 
three days , Dose fi'eq uen cies o f l x Ida y were g ivCll at 09DO; 2 X Iday 
at 0900 and 2 100; 3 x/da y at 0900, 1500, and 2 IDO; 4 X/d ay at 
0900, '1300, 1700, and 2 100, Ea ch dose co nsisted of approx im ate ly 
100 J.LI of fo rmula tion, w hich was admini stered with a co tto n-
tip pcd swab, A dru g formulati on and its co rrespondin g d ru g 
vehicle werc always tested o pposite each other at the sa m e ros-
tral-ca uda l level o n the g uinea pi g dorsum , O n the da y after 
CO ITl plction o f th e treatment reg im en, thc dorsum of each anim al 
was aga in depilatcd, and each infcction site was eva lu atcd with 
respect to numbcrs of lesions, d iameter oflcs ions, and totallcsion 
area by meth ods prev iously described [2 11 , 
Measurel11ent of the Stratum Corneum Drug Reservoir To 
cxalTline thc concentration g radient o f dru g w ithin the stratum 
cornclIm , IOO ILl of IJI-I\lDU formu latio ns were app lied to each 
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Figure 1. Proced ure to determine the co rrL'i ation be twecn therapeutic 
dficlCY of wpied IDU :,nd the q uantit y of IDU in g uinea pig stratum 
co rneUi11 , Two arcas on th e upper half of each animal were used for 
eva luatio n o f efticacy and two arcas o n thc lowcr half we rc used fo r 
qU3nt itarion of IDU by t:'pe stripin g, lododeox yurid inc was assayed in 
t:,pc speci mcns by flu o rescent exci tat ion spectrophotom etry , 
of 4 uninfected areas o n the backs of g uinea pigs 24 h after de-
pilati o n, The drug was gentl y distribu ted over a skin surfacc 
appli ca tion area o f 6 cm ~ , At des ignated time intervals fo llowing 
drug app li ca ti o n, the anima ls were anestheti zl'd w ith illtrapcri-
tonea l sodium pentobarbit:11 and cxccss d ru g a t the skin surf.1 ce 
W ;' 5 rem ovcd b y gelHl y w ipin g the arc:' three tim es w ith alcohol 
sw:,bs (S teri le Wcbco l, I(enda ll Co " B osto n. Massachu se tts). The 
skin sur face was th cn allowed to air d ry fo r .5 min ;lIld the stratum 
co rn ell lll was removed from the trcated a rea s b y I () st rippin gs 
with adhesive scotch tape (#3750- g, 3M In c., St. Paul , Minne-
sota), Thc co ncClltrati o n g radient of drug was dete rmined by 
m easurin g each of th e 10 pieces of tape in a scintill ation co untcr. 
Each st rip was weig hed befo re and after s trippin g, :lild differentia l 
weight was considered as the mass o f the stratum corn eUn1 r e-
movcd, T hc concentrati o n o flDU in each strip in m g JDU /g o f 
t issue was then calculated, 
To co mpare th c amo Lint of IDU in the st ratum co rneum w ith 
efft cacy against H SV -I . infection , approxima tely 100 ILl of dif-
ferent dru " fo rmul at ions we rc app li cd o nce to two 6-cm ~ un in-
feeted :lI'eas on the lower half o f the backs of guinea pi gs 24 h 
after dcpibtion (Fig I). In studies exa minin g IDU fo rmul atio ns 
g ivcn at differcnt frequ encies, all 4 qu adra nts o n th e backs of 
g uin ea pigs were used, Treated areas were taped stripped as dc-
scribed above , To assay IOU in these experim ents, th e 10 tape 
strips from each area were pla ced together in a bea ker colltainin g 
25 ml o f m et han 011 water (80 :20), T he IDU fro m the strips was 
ex tra cted by soa kin g in the so lvent ovcrnig ht :lI1d the so lvent then 
completel y eva po rated on a heatin g plate, T he dry residu e was 
redi ssolved ill 2 III I of DMSO :l IJ d the iodi ne content in each 
sa mple was anal yzed by Ao urescent excitati on spectrop ho tomet ry 
122,231, 
RES ULTS 
Pharmacokinetics ofIDU in the Stratum Corneum of Guinea 
Pigs Following a Single Application The co ncentration of 
IDU in th e stratum co rneum of g uin ea pi gs was dctermincd by 
ta pe st ripin g at specified time periods fo ll owi ng J sin g le appli-
ca ti on o fa tes t fo rmul at ion contain in g 15% IDU , 80'Yo DMSO , 
and 5% wa te r, The IDU co ncentration (m g ID U fg of tissue) by 
serial tim e interva ls and num bc r o f tape strips is sho',.vn in Fi g 2, 
The fi rst tapc strip rem oves stratum co rnculll fi'o lll the sur face 
o f th c skin and sub 'Cqucnt strips prog ress ivel y rem ove lowe r 
b yers o f th e stratum co rn cum as the num ber of tape strips in-
crcases 11 6 1, T he resu lts show:l concclltrati o n g rad ient at d ifferel1t 
tapc le vels. T he I I) U concentrati on w as hi ghest o n the sur facc of 
thc skin and then decreased in th e lower b ycrs of th e st ratum 
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Figure 2. Thc cO ll cell tr,uio ll of IDU in the s tr~tt l111 corn eUi11 by time 
interva ls after a sing le top ical dose alld by depth in the stratulll co rneUi11 
cxpressed as the r ~ nk o rder of 10 tape strip specim ens. T he first t~pe 
specimen takc n was N o. I . T he dJ t~ show n arc the l11 e'"1 IDU cOllccn-
tratio n of pairs of specimCll s. IDU was ass ~yed as [JHjlD U ill a sc intil-
latio n Co ulltcr alld tissue w~s q UJ ntitated by we ig hing the t~pe befo re and 
after stripping. 
corn eull1 . With the exception of the 0 .25-h till1 e peri od, these 
plo ts of d ru g conccntratio n vcrsus number o f strippin gs app rox-
im ate a pa rabo li c cu rve . The highes t conccntrati o n of IO U in th e 
stratum co rn eum (10 co mbin ed strips) occurred 1 h after appli-
ca ti on (70 mg IOU /g of ti ss ue). The co nccntrati o n of IOU g rad -
uall y dccreased over the nex t 3-24 h . 
Correlation Between the Therapeutic Efficacy of Topical 
IDU and the Quantity of IDU in the Stratum Corneum 
Wc h ypoth es ized that the th erapeuti c efficacy of top ica l ad min-
istration o f anti virals shoul d correl ate w ith the peak co ncentrat ion 
of dru g in th e stratull1 corn eum . To tcst this hypo th es is, we Ill ade 
measurements of the qu antity of IOU in the stratum co rneum 
(tota l IOU in lU tape st rips) on th e backs of 28 guin ea pi gs in 
vivo 2 h after a topica l application of seven diffe rcnt conccntra-
tions o f! OU in OMSO. The effi cacy of these forlll u lations aga inst 
experim cntal H SV-I infcction was tcs ted concurrcntl y in thc sa me 
g ro up of an im als. Fi gurc 1 depi cts the proccdure. 
T hc rcsults o f th cse stu d ies arc show n in T able I. The qu antity 
of IOU in th e st ratum co rn eum in creascd with an in creasc in 
eith er IOU or O M SO concentration in the formu lati on . The 
fo rmub tio n conta ini ng 15% IO U , 80% OMSO provid ed an 80-
fo ld higher am o unt of dru g in the stratum CO rneum than the 
0. 1 % IOU, 50% OM SO formu lati on (1524 vs 19 f-Lg IOU). Ef-
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Figu re 3. Rd~tion s hip between the quantity of IDU in the stratum Co r-
neul1l and the percent red uct io n in the num ber of lesio ns w hen different 
fo rmulatio ns of IDU in DMSO (% IDU / % I MSO) were used to treat 
an e"per imental cutaneous H SV-I in fect io n in g u inea pigs. T rea tm ents 
were g ive n 4 X Ida I' fo r 3 da ys. J-lori :(l lI rn l {'III'S rep resent the m can :±: SD . 
See T~b l e I fo r o thcr dct~i l s. 
and ro tal lesion area b y IDU fo rmul ati ons co mpared to treatm cnt 
w ith th e co rrespond ing dru g vehicle . Efficacy in creased w ith in-
crease in eith er IOU o r OM SO concentrati on in the fo rmubtio n . 
Figure 3 shows a lin ea r relations hi p betwee n the percellt red ucti on 
in number of les ions versus the am oun t of IO U in th e strat um 
co rn eum (r = 0.97) . A similar re lati onship was also obse rvcd 
w hen percent redu ction in rota l les ion area was plotted aga inst 
the amo unt of IDU in th e stratu m co rneum (r = 0.95, figurc not 
show n). 
Effect of Different Dosing Frequencies and Applied Drug 
Concentrations on the Amount of IDU in the Skin and on 
Therapeutic Efficacy T he kin eti cs of drug in th e stratulll Co r-
neum fo r 1% IDU , 50% OM SO; 3% IOU , 80% DMSO; an d 
15% IDU , 80% OMSO fo rmul ati ons ove r a peri od of 24 h fo l-
lowin g 1, 2,3, o r 4 app lica ti ons per da y wc re studied in 3') g uin ea 
pigs. In this stud y, all 4 areas of depi lated dorsulll were used for 
d ru g assays and in fecti ons were studied late r in a separate g ro up 
of anim als. At the end of specific appli cat ion time periods, excess 
d ru g rem ainin g on the sk in surbce was carefu ll y w iped off and 
the skin site was stri pped ten tim es w ith tape and assa yed for 
IOU by Auo rescent excitation spectrop hoto metry. 
Fo r each of th e three IOU fo rmul ations, data p lo ts indi ca ted 
th at the multiple dose regimCl1s led to accumulation of IOU in 
th e stratum co rn eum (Fig 4). T he amo unt of IOU in th e stratum 
corn eum peaked approx im ately 2 h afte r each top ica l dru g ap-
p li ca tion , consistent with the previo us stud y (see above) . T he 
number of IOU peaks co rres ponded to the number of to pical 
d ru g appli ca tion s per da y. The cUlllul ative alllount of IOU in the 
stratum corn eum over 24 h (a rea under the curve) in creased with 
Table I. Effect o f Oifferent T o pi ca l IOU Formu lations on the Q uantity of IOU in G uin ea Pig Stratum Corn eum and Efficacy in 
the Trea tm ent of Expe rim enta l H SV-l Infection" 
IDUIDM SO 









IDU in Stratum 
Corneum " (/-L g) 
19. 1 ± 8. 1' 
47 .5 ± 14. 1 
102.6 ± 22.5 
148.4 ± 33. 5 
215.2 ± 20.4 
786. 1 ± 162.4 
152'1 . 1 ± 349. 1 
"Trca tmCl1t was given 4x/day fo r 3 days. 
"Tota l from 10 tape strippin gs two hours after J single dose. 
'Mean ± SO. n = 4-8. 
' Mea n ± SO. " = 3-4. 
IDU. lododcoxyuridi ll c; OMSO. dimethylsulfox ide. 
Reductio n of 
Number of Les io ns 
(%) 
- 1.2 ± 27.6" 
16.3 ± 15.3 
35.5 ± 24.0 
34.2 ± 18.8 
68.9 ± 14.2 
84.9 ± 8.6 
90.7 ± 4.0 
Reductio n of 
Les io n Area 
(%) 
13.0 ± 22.2" 
47 .1 ± 8.6 
50.2 ± 19. 1 
67.2 ± 8. 1 
79.7 ± 14. 1 
88.2 ± 7.4 
93.7 ± 3.2 
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Figure 4. The kinetics of ID U ill the str~ tllm 
co rneum fo llowing single ~nd multipl e topica l 
app lications of three different lIJU formula-
tions. (solid sqllares) 1% IDU, 50% DMSO, 49% 
water; (OpCII circles) 3% IDU, SO% DMSO, 17% 
water; (so lid cirrles) 15% IOU, SO% DMSO, 5% 
wa ter. Arrows rl'p rCSl' lH tim e of ad l11ini s tr~tion 
of each topi ca l dose. Each point repreSl'IHS the 



























the st reng th of the applied fo rmulatio n and with the number o f 
d ru g appli cat io ns up to 3 X Iday (Table II ). 
The effect of frequency of topical drug app li ca tio n pe r day o n 
the efficacy of the three IDU fo rmul ations in v ivo was studied 
in a g uin ea pig m odel of cutaneo us HSV-l infect io n. Thirty an-
im a ls were inoculated with HSV-l Ell S as described above at-l 
loca tio ns o n the dorsum , and the infectio n sites were treated 
topically with 1% IDU, 50% DMSO; 50% DMSO vehicie; 3% 
[D U , 80% DMSO; 80% DMSO vehicle; 15% !DU, 80% DMSO; 
a nd 80% DM SO vehicle. Four different daily dos in g frequ encies 
wen: examincd, I, 2, 3, or 4 tim es a da y, as in thl' pri o r kin etics 
stud y . Within each dosing frequency, efficacy of the different 
form ulatio ns co rrelated with the appli ed concentrati o n o f IDU 
(Table II). For each of the fo rmulat io ns, drug efficacy increased 
wi th the number of dru g applications up to 3 X Iday , but did no t 
signifi ca ntl y improve by m ost meas ures w hen the number of dail y 
ap p li ca tio ns was increased to 4. 
D ISCUSS ION 
T h e present studies represent the first report of antiviral dru g 
CO il centratio ns in skin and th e relation of th esc va lucs to clini ca l 
effect aga in st HSV infection. The measurcments wcre obtained 
by m ea ns of tcn tapc strippin gs at serial tim e periods. Histolog ic 
s tudics in o ur lab have rcvea led that ten strippin gs rem oves th e 
8 
t l( I doy t 2 x/da , 
3 x I da), 4 x/da, 
t t 
12 16 20 24 4 8 12 16 20 24 
TIME (hours) 
m aj o rity of th c g uinca pig stratum co rn cum (N. V. Shcth, un-
pub lishcd data) . Pl ots of IDU conccntrat io n in th e stratum co r-
nculll vcrsus numbcr of tape strippin gs gavc a parabo lic curve. 
Thcse pl o ts arc in agreement w ith similar work do nc b y Schaefcr 
and cowo rkers 11 JI and are consistent w ith Fick 's la w o f pass ive 
diffusio n. The conccntrati on of IDU in the st ratulll co rneum 
peaked in 1-3 h and g rad uall y decl in ed betwccn 3- 24 h. T hcse 
data likcl y reAcct a combi nati on of sevcral facrors: a rapid inAu x 
of IDU in ro th e skin effected by DM SO thro ug h a change in the 
permeability coeffi cient of the stratum co rn cum ; a return of th e 
permeabi li ty coeffici cnt to no rm al after approximately 3 h 126]; 
and diffusion of IDU o ut of th c stratulll co rn cum into thc lower 
la yers of the sk in . 
Since the IDU concentratio n peaked approximately 2 h afte r a 
si ng le topica l drug app li ca tio n , this tim e peri od was choscn to 
stud y the relati o nship between the q uantity o flDU in the stratum 
co rneum for seven d iffercllt dru g formulations and thc therapeutic 
cfficacy of th ese formulations in o ur g uin ea pig Ill odel. Thc thcr-
apeuti c effi cacy as wcH as the am ount of IDU in th e stra tum 
co rneulll in crcascd w ith an in creasc in eithcr th e IDU o r thc 
DMSO concentration in thc formulation . This is co nsistent with 
th c penctration enhancing cffcct o f DMSO, w hi ch is generall y 
propo rtio nal to thc co ncclltratio n of DMSO at co ncentrati o ns 
abovc 60-70% 11 4,27,28]. Whcn th e amoullt of drug in th e stra-
Table II. Eftcct of Differcnt Dai ly D osc Frequencies o n the C umulati ve Quantity of IDU in the Stratum Co rn cum and o n the 
In Vi vo Efficacy ofThrec Topica l IDU Formulations 
Cumul~ti vc IDU 
IDUIDMSO in the Stratum 
Formulations Drug App li cations Corneulll" (f.l g 
(%1%) per D3Y h/clll 2) 




3/S0 IX 593 
2X 1,224 
3X I,S I5 
4X 1,759 
15/S0 IX 4, 153 
2X 5,S82 
3X 11 ,525 
4X S.748 
"C:1icuiJ tl'd a re3 under the curve ov(' r a 24-h pe riod of IlI CaS llrCIllI..' IHS. Sec Fig 4 for dera ils. 
bM e' l1 :!: SE M , 11 = 4. 
Reduction of Number 
of Lesions (%) 
- IS. I ± 13.S" 
10.S ± 7.5 
39.0 ± \ 1.8 
35.5 ± 11. 9 
9.3 ± 7. 1 
29.4 ± 6.3 
43.S ± S.5 
6S.9±7. 1 
33.4 ± 4.S 
51. 0 ± 12.S 
SO.9 ± 4.6 




- 10.6 ± 35.6" 
46.7 ± 7.S 
65.2 ± 7. 1 
50.2 ± 9.6 
42.9 ± 9.6 
7 1. 4 ± 2.7 
69.0 ± 7.3 
7S.6 ± 7.0 
59.0 ± 6.0 
79.2 ± 4.2 
90.4 ± 2.7 
93.7 ± 1. 6 
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tLim co rn eum was plotted sem il ogaritilmica ll y aga ins t therapeutic 
efficacy expressed as reductio n in lesion number or tota l les ion 
area, there was a hi g h degree of co rrelation (I' = (l 'n and 0.95, 
respectively). 
Studies of diffe rent frequ encies of dai ly dosin g were performed 
to determine the treatment regim en w hi ch max imi zed clinica l 
effi cacy. For each o f three different IDU formulation s, effi cacy 
rea ched;l plateau at a dosin g frequen cy o f 3 X Ida y. The CUIllU-
Iati ve am o unt of II U in the stratum corneum (a rea under the 
curve) also reached a platea u at 3 x Ida y, sugges tin g that this 
meas ure of cutan eous antivira l kineti cs mi ght be use fu l in de-
slgnlll g trea tment reg l111 ens. 
Th e inte ra ction of topica ll y applied drugs with the stratulll 
co rn eulll m ay be viewed from seve ral perspectives . First, the 
stratum corn eum is co ns id ered the rate limiting barri er fo r th e 
penetratio n of dru g mol ecules into th e skin 11 -41. Secondl y, the 
stratum corneum m ay fun cti on as a reservo ir fo r drugs 11 7-1 9,24 /. 
Ro ug ier and associates 11 6 1 have docum ented th at the amo unt o f 
dru g in th e stratum co rn eum reser voir afte r a s in g le to pi ca l dose 
shows a stro ng co rrelat ion w ith to ta l sys temi c dru g abso rpti o n. 
Th e present st ud y extends th ese findin gs by dem o ns tratin g that 
the stratum co rn eum reservo ir of an antiviral ca n be p redi cti ve 
of the clinica l act ivity o f th e agen( aga inst cutan eo us HSV infec-
tio n. A third as pect of s tratum co rn eum pharm ace uti cs is the 
conce pt that dru g in the reservo ir m ay be available fo r therapeutic 
activity in the lower la yers o f the skin at subsequent times afte r 
an o ri g in al load in g dose . For exam ple , the skin blanchin g react io n 
due to corti cos tero ids occurs up to 15 days after its top ica l ap-
pli ca ti o n, w hen the area is reoccluded /1 0, 12, 18 /. lododcoxy u-
ridinc in the str:ltum corn eum mi g ht be able to serve :IS a sourcc 
o f dru g fo r th e infected basal ce lls o f th e epidermis. O ur data 
sugges t that this latte r h ypothes is is no t accurate , sin ce J sin g le 
dose of 15% IDU , 80'Yo DMSO loads the stratum co rn eum dru g 
reservoir for 24 h , but achieves o nl y m odest clini ca l effi cacy (Ta-
ble II ) . 
. The present inves ti ga ti o n ha s described a new meth odo logy to 
eva luate the skin penetration o f topica l anti virals for H SV infec-
tion s. Althou g h the idea l m easu rem ent (dru g concentrati on at th e 
site o f infection) ca nn o t ye t be acco mpli shed, determination o f 
stratum co rn eum dru g levels prov id es a rati o nal m ea ns to address 
th e questio ns of fo rmulation and dos in g. The stro ng co rrelati on 
we o btained between efficacy and peak lDU stratum co rneU111 
levels is likely due to the use of an proced ure for meas urin g drug 
diffusion in vivo and concurrent eva lu ation o f effi cacy in the sa me 
anima ls . The tape-strippin g m ethodo logy has the add iti ona l po-
tential advanta ge o f usc in vivo in human subj ects. 
TIl(' oll,h"l's arc .~m/(:(I" ,,, Dr. ja/ll es N elSOII , Director, Dio,~ ' IO" i( I?oriiologl' 
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